Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2012
03/28/2012EP1453508B1 Tempamine compositions and use against cellular oxidative damage
03/28/2012EP1432707B1 Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
03/28/2012EP1308438B9 3-substituted urea derivatives and medicinal use thereof
03/28/2012EP1284711B2 Process for making a blister package containing topiramate tablets
03/28/2012EP1272197B2 Combination of lecithin with ascorbic acid
03/28/2012EP1117689B1 Bone morphogenetic protein antagonists based on the mature protein
03/28/2012DE202010017530U1 Danazolverbindung zur Behandlung von Krankheiten Danazolverbindung for the treatment of diseases
03/28/2012CN202173613U 一种防卷边强透气的水杨酸苯酚贴膏 An anti-curling strong breathable salicylic acid phenol Plaster
03/28/2012CN1997363B Resistance-repellent retroviral protease inhibitors
03/28/2012CN1960969B Histamine H3 receptor agents, preparation method and therapeutic uses thereof
03/28/2012CN1882568B Pyrrol derivatives with antibacterial activity
03/28/2012CN1867572B Proteasome inhibitors and methods of using the same
03/28/2012CN1827605B 4,4-disubstituted-3,4-dihydro-2(1H)- quinolones and synthesis process and use thereof
03/28/2012CN1822827B Use of alpha-ketoglutaric acid for the treatment of malnutrition or high plasma glucose condition
03/28/2012CN1762341B Salvianolic acid compound for treating cardiovascular and cerebrovascular disease and liver disease, and application thereof
03/28/2012CN1668287B Use of 3-deoxyflavonoids in preparing medicine for inhibition of t-lymphocyte activation
03/28/2012CN1583063B Extraction of effective components from frankinscene and its preparation and use
03/28/2012CN102395592A Isothiazolo-pyrimidinedione derivatives as trpa1 modulators
03/28/2012CN102395590A Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections
03/28/2012CN102395589A Fused pyrrolopyridine derivative
03/28/2012CN102395588A Heterocyclic compounds, pharmaceutical compositions containing them, and their use as inhibitors of the glycine transporter 1
03/28/2012CN102395587A Pyridocarbazole type compounds and applications thereof
03/28/2012CN102395586A TRiazolopyridine derivatives as p38 map kinase inhibitors
03/28/2012CN102395585A Heteroaryls and their use as pi3k inhibitors
03/28/2012CN102395584A Compounds for the treatment of metabolic disorders
03/28/2012CN102395583A Isoxazole derivatives
03/28/2012CN102395581A Substituted 4-amino-5-benzoyl-2-(phenylamino)thiophene-3-carbonitriles and substituted 4-amino-5-benzoyl-2-(phenylamino)thiophene-3-carboxamides as tubulin polymerization inhibitors
03/28/2012CN102395580A Crystalline polymorphic form 631
03/28/2012CN102395579A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
03/28/2012CN102395578A Compounds for the treatment of metabolic disorders
03/28/2012CN102395577A Diazepinedione derivative
03/28/2012CN102395576A Jak kinase modulating quinazoline derivatives and methods of use thereof
03/28/2012CN102395575A P38map kinase inhibitor
03/28/2012CN102395572A 1,3,4-oxadiazole derivatives and their uses to treat diabetes
03/28/2012CN102395571A Novel triazine derivative and pharmaceutical composition containing same
03/28/2012CN102395567A Triazole and imidazole derivatives for use as tgr5 agonists in the treatment of diabetes and obesity
03/28/2012CN102395562A Novel p2x7r antagonists and their use
03/28/2012CN102395560A Dihydrolipoic acid derivatives comprising nitric oxide and therapeutic uses thereof
03/28/2012CN102395558A Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
03/28/2012CN102395557A Kinase inhibitor compounds
03/28/2012CN102395401A Drug delivery through hydrogel plugs
03/28/2012CN102395374A Methods of treating cancers with her3 antisense oligonucleotides
03/28/2012CN102395373A Method for on-demand contraception
03/28/2012CN102395372A Benzodiazepine derivative for the treatment of hematopoietic neoplasm and leukemia
03/28/2012CN102395371A 5-ht4 receptor agonist compounds for treatment of cognitive disorders
03/28/2012CN102395370A Methods for inhibiting angiogenesis with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin
03/28/2012CN102395368A Methods to treat cancer
03/28/2012CN102395367A Use of nifuratel to treat infections caused by atopobium species
03/28/2012CN102395366A Method of decreasing pro-adam10 secretase and/or beta secretase levels
03/28/2012CN102395365A Combination of avermectins or mylbemycins with adrenergic receptors for treating or preventing skin diseases
03/28/2012CN102395364A Pharmaceutical compositions
03/28/2012CN102395363A Methods and compositions of pi-3 kinase inhibitors for treating fibrosis
03/28/2012CN102395362A Sublingual spray formulation comprising dihydroartemesinin
03/28/2012CN102395361A Bioavailable capsule compositions of amorphous alpha-(n-sulfonamido)acetamide compound
03/28/2012CN102395360A Precompacted fast-disintegrating formulations of compounds with a low oral bioavailability
03/28/2012CN102395358A Uses of nk receptor antagonists
03/28/2012CN102395276A Controlled release pharmaceutical formulations of nitazoxanide
03/28/2012CN102395275A Methods for treating multiple sclerosis using tetracyclic pyrazinoindoles
03/28/2012CN102395274A Anti-fungal formulation
03/28/2012CN102395273A Thienopyridine derivatives for the treatment and prevention of dengue virus infections
03/28/2012CN102395270A Novel compounds, pharmaceutical compositions containing same, methods of use for same, and methods for preparing same
03/28/2012CN102395269A Antiviral agent and cleanser
03/28/2012CN102392028A Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
03/28/2012CN102391499A Preparation method of polymer for quickly releasing active components of masticinic acid under exciting of reduction
03/28/2012CN102391389A Colloidal bismuth pectin compound and medicinal composition thereof, and preparation methods and application thereof
03/28/2012CN102391372A Target of liver cancer drug therapy and application of the target
03/28/2012CN102391356A Steroid n-glycoside analogue taking dihydro-pyranoid ring as D ring and preparation and application thereof
03/28/2012CN102391353A Walsuralactam A and preparation method and application to medicament thereof
03/28/2012CN102391352A Amino acid derivatives of rotundic acid and application of derivatives in preparation of antitumor medicines
03/28/2012CN102391349A New honeysuckle lonimacranthoide and preparation method and application thereof
03/28/2012CN102391346A Oleanane saponin compounds and purpose thereof
03/28/2012CN102391336A Compound and preparation method and use thereof
03/28/2012CN102391335A Isopentene flavonol glycoside derivative and preparation method and application thereof
03/28/2012CN102391332A Liver protecting compound and preparation method and use thereof
03/28/2012CN102391323A Tetrahydro-beta-carboline derivative, preparation method thereof and use thereof
03/28/2012CN102391305A Phosphate disodium salt hydrate of propofol hydroxyacid ester and preparation method and application thereof
03/28/2012CN102391287A Levo-fluoroquinolone C3 bisazole methyl sulfide, preparation method and application thereof
03/28/2012CN102391283A Clopidogrel hydrogen sulfate compound and preparation method thereof
03/28/2012CN102391279A Methyl 3,4-seco-4-hydroxy-3-cimigenolate, medicinal composition containing same and preparation method and application thereof
03/28/2012CN102391272A 1,4-disubstituent-1,4-dihydrobenzopranyl [4,3-c] pyrazole compounds
03/28/2012CN102391271A Improved method for making analgesics
03/28/2012CN102391267A Method for producing chiral 8-(3-amino-piperidin-1-yl)-xanthines
03/28/2012CN102391263A Deuteroacetyl-containing kinase inhibitor
03/28/2012CN102391262A Antimicrobial compound containing 3-carboxyalkyl rhodanine derivative
03/28/2012CN102391260A 3-ketone-6-substituted-benzofuran compound as well as preparation method and application thereof
03/28/2012CN102391258A Amino-substituted flavone compound and preparation and use thereof
03/28/2012CN102391255A Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
03/28/2012CN102391251A Chemokine receptor antagonists
03/28/2012CN102391250A Dabigatran compound and preparation method and medicinal composition thereof
03/28/2012CN102391246A 3-fluorine-5-(trifluoromethyl)-N-(2-(2-thienyl)ethyl)benzamide and application thereof
03/28/2012CN102391231A Flavonoid compound and application thereof in preparation of pharmaceutical preparation
03/28/2012CN102391225A Mycophenolic acid derivatives Penicacids A, B, C and their application in preparing immunosuppression medicaments
03/28/2012CN102391222A Novel hydroxamates as therapeutic agents
03/28/2012CN102391221A Hypolipidemic compound and preparation method and use thereof
03/28/2012CN102391212A Ginseng epoxy alkynol compound and preparation and use thereof
03/28/2012CN102391209A Mesylate cinepazide crystal form II and preparation method thereof
03/28/2012CN102391207A N-(2-(substituted benzo- thiazole-2- amino formacyl) -phenyl group) - benzamide, as well as preparation method and usages thereof
03/28/2012CN102391204A Chiral 2,4-disubstituted-thaizolidinone compounds and preparation method and application thereof in preparation of anticancer medicaments
03/28/2012CN102391192A Preparation method and application of shikimic acid ligustrazine
03/28/2012CN102391191A Piperazine di-thiocarboxylic acid ester derivative of 2,4-di-aminoquinazoline, as well as preparation method and anti-tumor application of the derivative
1 ... 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 ... 7860